Вклад участника
- 12:13, 29 апреля 2024 (разн. | история) . . (+4451) . . Н Opinion-Feel-Decision-Health-System-Supplementation-Cancer-Prevention-Report-Wellness-Organisation-Expectancies-Use-y (Opinion-Feel-Decision-Health-System-Supplementation-Cancer-Prevention-Report-Wellness-Organisation-Expectancies-Use-y) (текущая)
- 04:54, 26 апреля 2024 (разн. | история) . . (+5072) . . Н States-Medicines-Postscript-Supplement-Health-Education-Act-Dshea-s (States-Medicines-Postscript-Supplement-Health-Education-Act-Dshea-s) (текущая)
- 09:01, 25 апреля 2024 (разн. | история) . . (+4732) . . Н Outcome-Increase-Count-Functionality-Cells-Lr-Lymphoid-Cell-Production-Objective-Survey-Hurt-Malnutrition-Myeloid-Lymphoid-Cell-Development-Lien-Bone-Marrow-Bm-y (Outcome-Increase-Count-Functionality-Cells-Lr-Lymphoid-Cell-Production-Objective-Survey-Hurt-Malnutrition-Myeloid-Lymphoid-Cell-Development-Lien-Bone-Marrow-Bm-y) (текущая)
- 08:41, 24 апреля 2024 (разн. | история) . . (+4605) . . Н Attest-Accompaniment-Studies-Result-Supplementation-Serum-Factor-Level-Depression-Anxiety-Symptom-Haemodialysis-Background-Aim-Study-Effect-Supplementation-Low-Anxiousness-Symptoms-Factor-Dismantle-l (Attest-Accompaniment-Studies-Result-Supplementation-Serum-Factor-Level-Depression-Anxiety-Symptom-Haemodialysis-Background-Aim-Study-Effect-Supplementation-Low-Anxiousness-Symptoms-Factor-Dismantle-l) (текущая)
- 11:46, 23 апреля 2024 (разн. | история) . . (+4854) . . Н Addition-Chm-Expressions-Formulation-Expressions-Mrna-Expressions-Well-Expressions-P-x (Addition-Chm-Expressions-Formulation-Expressions-Mrna-Expressions-Well-Expressions-P-x) (текущая)
- 10:49, 22 апреля 2024 (разн. | история) . . (+4901) . . Н Certify-Combinations-Antioxidants-Advantage-Effects-Antioxidants-Forbid-Reverse-Ad-q (Certify-Combinations-Antioxidants-Advantage-Effects-Antioxidants-Forbid-Reverse-Ad-q) (текущая)
- 09:54, 19 апреля 2024 (разн. | история) . . (+4359) . . Н None-Mixtures-Dose-Liver-Cell-Samples-Infusion-Perniciousness-Hepatocellular-Carcinoma-Cell-Line-Effects-Action-Activity-Plant-e (None-Mixtures-Dose-Liver-Cell-Samples-Infusion-Perniciousness-Hepatocellular-Carcinoma-Cell-Line-Effects-Action-Activity-Plant-e) (текущая)
- 08:57, 18 апреля 2024 (разн. | история) . . (+4923) . . Н Explore-Bear-Hospital-Astrazeneca-Plc-Squibb-Company-Pharmaceutic-Health-Neuralstem-Inc-Pamlab-Llc-Pfizer-Inc-b (Explore-Bear-Hospital-Astrazeneca-Plc-Squibb-Company-Pharmaceutic-Health-Neuralstem-Inc-Pamlab-Llc-Pfizer-Inc-b) (текущая)
- 07:17, 17 апреля 2024 (разн. | история) . . (+4909) . . Н Guilongtonluofang--NinjinYoeito--And-Antioxidants-Showed-Various-Stage-Of-Potential-Strength-q (Guilongtonluofang--NinjinYoeito--And-Antioxidants-Showed-Various-Stage-Of-Potential-Strength-q) (текущая)
- 06:43, 15 апреля 2024 (разн. | история) . . (+4761) . . Н Villi-Mucosal-Thickness-Rats-Comparison-Ensure-Brute-Heat-c (Villi-Mucosal-Thickness-Rats-Comparison-Ensure-Brute-Heat-c) (текущая)
- 10:02, 9 апреля 2024 (разн. | история) . . (+4852) . . Н Bread-Check-Showed-Overtone-Inhibition-Of-MVS-And-Zinc-On-EC-Migration-y (Bread-Check-Showed-Overtone-Inhibition-Of-MVS-And-Zinc-On-EC-Migration-y) (текущая)
- 11:34, 8 апреля 2024 (разн. | история) . . (+5400) . . Н School-of-Life-Sciences-Shandong-University-Qingdao-266237-Shandong-China-Department-of-Rehabilitation-Qilu-Hospital-Cheeloo-College-of-Medicine-Shandong-University-Jinan-250012-Shandong-China-a (School-of-Life-Sciences-Shandong-University-Qingdao-266237-Shandong-China-Department-of-Rehabilitation-Qilu-Hospital-Cheeloo-College-of-Medicine-Shandong-University-Jinan-250012-Shandong-China-a) (текущая)
- 05:48, 3 апреля 2024 (разн. | история) . . (+5273) . . Н Annihilation-essay-liquid-Svf-Layer-Matrix-layer-e (annihilation-essay-liquid-Svf-Layer-Matrix-layer-e) (текущая)
- 11:37, 2 апреля 2024 (разн. | история) . . (+6311) . . Н -The-studies-show-which-a-couple-of-T-mobile-or-portable-sorts-can-be-found-any-proximal-a-single-secreting-GLP1-and-perhaps-CCK-and-also-neurotensin-plus-a-distal-one-particular-secreting-GLP1-along-with-PYY-k (-The-studies-show-which-a-couple-of-T-mobile-or-portable-sorts-can-be-found-any-proximal-a-single-secreting-GLP1-and-perhaps-CCK-and-also-neurotensin-plus-a-distal-one-particular-secreting-GLP1-along-with-PYY-k) (текущая)
- 10:25, 1 апреля 2024 (разн. | история) . . (+6354) . . Н -These-kinds-of-SC-as-well-as-ICV-liraglutideinduced-consequences-had-been-inhibited-by-simply-50-as-well-as-70-respectively-simply-by-pretreatment-together-with-atropine-any-muscarinic-receptor-blocker-n (-These-kinds-of-SC-as-well-as-ICV-liraglutideinduced-consequences-had-been-inhibited-by-simply-50-as-well-as-70-respectively-simply-by-pretreatment-together-with-atropine-any-muscarinic-receptor-blocker-n) (текущая)
- 04:35, 1 апреля 2024 (разн. | история) . . (+5357) . . Н Amount-data-Effect-eatage-treatment-Milk-tone-Dairy-Bostaurus-c (Amount-data-Effect-eatage-treatment-Milk-tone-Dairy-Bostaurus-c) (текущая)
- 06:11, 29 марта 2024 (разн. | история) . . (+5024) . . Н Solvent-Supplementation-Vitamin-course-CRP-story-j (solvent-Supplementation-Vitamin-course-CRP-story-j) (текущая)
- 05:41, 28 марта 2024 (разн. | история) . . (+6831) . . Н -This-may-reflect-wide-variability-from-the-prescribing-associated-with-more-modern-agents-t (-This-may-reflect-wide-variability-from-the-prescribing-associated-with-more-modern-agents-t) (текущая)
- 07:17, 25 марта 2024 (разн. | история) . . (+6347) . . Н -However-sideline-GLP1-management-simply-by-intraperitoneal-shot-acquired-small-effect-f (-However-sideline-GLP1-management-simply-by-intraperitoneal-shot-acquired-small-effect-f) (текущая)
- 07:09, 22 марта 2024 (разн. | история) . . (+5912) . . Н -The-outcome-established-that-GLP1-agonists-will-benefit-outlined-offmedication-generator-ratings-throughout-Parkinsons-Disease-and-improve-psychological-wellbeing-i (-The-outcome-established-that-GLP1-agonists-will-benefit-outlined-offmedication-generator-ratings-throughout-Parkinsons-Disease-and-improve-psychological-wellbeing-i) (текущая)
- 07:42, 21 марта 2024 (разн. | история) . . (+6241) . . Н Advancement-inside-glycaemic-details-using-SGLT2-inhibitor-and-GLP1-agonist-together-in-an-teen-along-with-diabetes-mellitus-as-well-as-PraderWilli-syndrome-a-school-Private-hospitals-Bristol-National-health-service-Base-Rely-on-Bristol-United-kingdom-c (Advancement-inside-glycaemic-details-using-SGLT2-inhibitor-and-GLP1-agonist-together-in-an-teen-along-with-diabetes-mellitus-as-well-as-PraderWilli-syndrome-a-school-Private-hospitals-Bristol-National-health-service-Base-Rely-on-Bristol-United-kingdom-c) (текущая)
- 07:34, 18 марта 2024 (разн. | история) . . (+5382) . . Н -Despite-an-abundance-of-published-glucose-lowering-protocols-and-the-known-negative-outcomes-associated-with-perioperative-hyperglycaemia-in-DM-there-is-no-evidence-regarding-the-optimal-intraoperative-glucose-lowering-treatment-e (-Despite-an-abundance-of-published-glucose-lowering-protocols-and-the-known-negative-outcomes-associated-with-perioperative-hyperglycaemia-in-DM-there-is-no-evidence-regarding-the-optimal-intraoperative-glucose-lowering-treatment-e) (текущая)
- 06:18, 15 марта 2024 (разн. | история) . . (+5049) . . Н Parents-therapy-count-questionnaire-b (Parents-therapy-count-questionnaire-b) (текущая)
- 09:27, 11 марта 2024 (разн. | история) . . (+6033) . . Н Results-Sufferers-using-NAFLD-exhibited-fasting-hyperglucagonaemia-but-unchanged-GLP1mediated-glucagon-reductions-separately-of-plasma-televisions-blood-sugar-concentrations-of-mit-l (Results-Sufferers-using-NAFLD-exhibited-fasting-hyperglucagonaemia-but-unchanged-GLP1mediated-glucagon-reductions-separately-of-plasma-televisions-blood-sugar-concentrations-of-mit-l) (текущая)
- 08:20, 7 марта 2024 (разн. | история) . . (+5207) . . Н -We-evaluated-nave-fasting-serum-GLP1-and-GLP2-levels-in-METHODS-Fiftyfive-IF-patients-with-median-age-4-IQR-112-years-and-47-matched-healthy-controls-underwent-measurement-of-fasting-serum-GLP1-and-GLP2-p (-We-evaluated-nave-fasting-serum-GLP1-and-GLP2-levels-in-METHODS-Fiftyfive-IF-patients-with-median-age-4-IQR-112-years-and-47-matched-healthy-controls-underwent-measurement-of-fasting-serum-GLP1-and-GLP2-p) (текущая)
- 07:45, 6 марта 2024 (разн. | история) . . (+6303) . . Н Clinical-of-Allnatural-Drugs-Heart-regarding-Medication-Breakthrough-Tiongkok-Pharmaceutical-drug-University-Twentyfour-Tongjiaxiang-Nanjing-210009-Cina-p (Clinical-of-Allnatural-Drugs-Heart-regarding-Medication-Breakthrough-Tiongkok-Pharmaceutical-drug-University-Twentyfour-Tongjiaxiang-Nanjing-210009-Cina-p) (текущая)
- 07:19, 6 марта 2024 (разн. | история) . . (+5466) . . Н -GLP1-levels-after-the-RYGB-reversal-decreased-by-76-and-70-respectively-from-their-prereversal-levels-and-to-the-level-of-nonhypoglycemic-postRYGB-controls-n (-GLP1-levels-after-the-RYGB-reversal-decreased-by-76-and-70-respectively-from-their-prereversal-levels-and-to-the-level-of-nonhypoglycemic-postRYGB-controls-n) (текущая)
- 09:53, 1 марта 2024 (разн. | история) . . (+5650) . . Н -247--59-atropine-pmoll--min-P--0001-o (-247--59-atropine-pmoll--min-P--0001-o) (текущая)
- 07:24, 1 марта 2024 (разн. | история) . . (+5402) . . Н Treated-with-an-OAD-oral-antidiabetic-drug-monotherapy-69-with-metformin-and-had-HbA1c--or--10-were-enrolled-w (treated-with-an-OAD-oral-antidiabetic-drug-monotherapy-69-with-metformin-and-had-HbA1c--or--10-were-enrolled-w) (текущая)
- 04:57, 29 февраля 2024 (разн. | история) . . (+6396) . . Н -Many-of-us-next-looked-at-monotherapy-using-desfluorositagliptin-any-dipeptidyl-peptidase4-DPP4-inhibitor-over-these-mouse-groupings-j (-Many-of-us-next-looked-at-monotherapy-using-desfluorositagliptin-any-dipeptidyl-peptidase4-DPP4-inhibitor-over-these-mouse-groupings-j) (текущая)
- 09:06, 28 февраля 2024 (разн. | история) . . (+6045) . . Н -We-calculated-the-inclination-credit-score-involving-commencing-GLP1-RAs-in-comparison-with-that-of-beginning-nonGLP1-RAs-as-a-function-of-standard-covariates-using-logistic-regression-u (-We-calculated-the-inclination-credit-score-involving-commencing-GLP1-RAs-in-comparison-with-that-of-beginning-nonGLP1-RAs-as-a-function-of-standard-covariates-using-logistic-regression-u) (текущая)
- 08:11, 27 февраля 2024 (разн. | история) . . (+5499) . . Н PURPOSE-The-cardiovascular-safety-outcomes-of-newer-antidiabetic-agents-were-SUMMARY-Seven-randomized-placebocontrolled-trials-involving-patients-with-type-2-diabetes-mellitus-with-or-at-risk-for-cardiovascular-disease-were-reviewed-q (PURPOSE-The-cardiovascular-safety-outcomes-of-newer-antidiabetic-agents-were-SUMMARY-Seven-randomized-placebocontrolled-trials-involving-patients-with-type-2-diabetes-mellitus-with-or-at-risk-for-cardiovascular-disease-were-reviewed-q) (текущая)
- 10:59, 23 февраля 2024 (разн. | история) . . (+5494) . . Н -Instead-the-gut-IEL-GLP1R-is-essential-for-the-full-effects-of-GLP1RAs-on-gut-microbiota-u (-Instead-the-gut-IEL-GLP1R-is-essential-for-the-full-effects-of-GLP1RAs-on-gut-microbiota-u) (текущая)
- 11:15, 21 февраля 2024 (разн. | история) . . (+6272) . . Н Final-results-GLP2-AUC-shown-a-substantial-postoperative-increase-945449-vs787602-p0037-GLP1-AUC-shown-a-new-nonsignificant-development-toward-boost-after-RYGB-709320-vs-z (Final-results-GLP2-AUC-shown-a-substantial-postoperative-increase-945449-vs787602-p0037-GLP1-AUC-shown-a-new-nonsignificant-development-toward-boost-after-RYGB-709320-vs-z) (текущая)
- 04:45, 21 февраля 2024 (разн. | история) . . (+6466) . . Н -Nonalcoholic-junk-liver-condition-NAFLD-is-associated-with-postoperative-hard-working-liver-disappointment-PLF-and-reduced-hard-working-liver-rejuvination-e (-Nonalcoholic-junk-liver-condition-NAFLD-is-associated-with-postoperative-hard-working-liver-disappointment-PLF-and-reduced-hard-working-liver-rejuvination-e) (текущая)
- 07:44, 18 февраля 2024 (разн. | история) . . (+6317) . . Н Glucosedependent-insulinotropic-peptide-GIP-and-also-glucagonlike-peptide1-GLP1-are-generally-powerful-generators-regarding-glucosedependent-the-hormone-insulin-release-any-trend-known-as-incretin-effect-g (Glucosedependent-insulinotropic-peptide-GIP-and-also-glucagonlike-peptide1-GLP1-are-generally-powerful-generators-regarding-glucosedependent-the-hormone-insulin-release-any-trend-known-as-incretin-effect-g) (текущая)